PharmaTelevision - The Future of Regenerative Medicine

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: The Future of Regenerative Medicine

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

As President of the world’s largest funding source for regenerative medicine Alan Trounson draws on his experience from his long career in research which extends back to the very beginnings of this groundbreaking area. He talks of his personal career and the birth of stem cell research and explains how the Institute will help to ensure that the science fulfils its potential.

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Origin of California Institute of Regenerative Medicine.

Fintan Walton:

Hello and welcome to PharmaVentures business review here in Melbourne, Australia. On this show we have Professor Alan Trounson who is the President of the California Institute of Regenerative Medicine based in San Francisco. Welcome to the show.

Alan Trounson:

Hi.

Fintan Walton:

The California Institute of Regenerative Medicine is a relatively new initiative that came out of basically the California politics.

Alan Trounson:

Yes.

Fintan Walton:

Proposition 71 which allowed the state to start funding basic stem cell research effectively and now you head up this institute which has about $3 billion worth of funding

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Alan Trounson

President

Alan Trounson is President of the California Institute of Regenerative Medicine in San Francisco, California. Prior to joining California Institute of Regenerative Medicine in January 2008, Dr. Alan Trounson was Professor of Stem Cell Sciences and Director of the Monash Immunology and Stem Cell Laboratories at Monash University, where he retains the title of Emeritus Professor. Dr. Alan Trounson founded the National Biotechnology Centre of Excellence 'Australian Stem Cell Centre'. Alan Trounson held various positions at Monash University beginning in 1977 and was appointed Director of the Centre for Early Human Development in 1985. He was awarded a Personal Chair in Obstetrics and Gynaecology/Paediatrics in 1991, and in 2003 was awarded a Personal Chair as Professor of Stem CellSciences. A Fellow of the Royal College of Obstetricians and Gynaecologists and an Honorary Fellow of the Australian and New Zealand College of Obstetricians and Gynaecologists, he was awarded an honorary doctorate by the faculty of medicine at the University of Brussels. Dr. Alan Trounson has been a pioneer of human in vitro fertilization (IVF) and associated reproductive technologies, the diagnosis of inherited genetic disease in pre-implantation embryos; the discovery and production of human embryonicstem cells and of their ability to be directed into neurons, prostate tissue and respiratory tissue.

California Institute of Regenerative Medicine

California Institute of Regenerative Medicine (CIRM) was established in early 2005 following the passage of Proposition 71, the California Stem Cell Research and Cures Initiative. The statewide ballot measure, which provided $3 billion in funding for stem cell research at California universities and research institutions, was approved by California voters on November 2, 2004, and called for the establishment of a new state agency to make grants and provide loans for stem cell research, research facilities and other vital research opportunities. The mission of California Institute of Regenerative Medicine is to support and advance stem cell research and regenerative medicine under the highest ethical and medical standards for the discovery and development of cures, therapies, diagnostics and research technologies to relieve human suffering from chronic disease and injury. To date, the California Institute of Regenerative Medicine governing board has approved 229 research grants totaling more than $614 million, making California Institute of Regenerative Medicine the largest source of funding for embryonic and pluripotentstem cell research in the world.